Tritonib 5mg Tablet

About

Tritonib 5mg Tablet, likely containing Imatinib, is a targeted therapy belonging to the class of tyrosine kinase inhibitors (TKIs). This 5mg tablet formulation, while a lower dose, is still potent in its mechanism of action, which involves selectively inhibiting the Bcr-Abl tyrosine kinase, a key driver in chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It also targets other receptor tyrosine kinases, such as KIT and PDGF-R, making it effective in gastrointestinal stromal tumors (GIST).

By blocking these specific signaling pathways, imatinib prevents the uncontrolled proliferation and survival of cancer cells. This precise mechanism offers a more targeted approach compared to conventional chemotherapy, leading to improved outcomes and a generally more favorable side effect profile for responsive cancers, significantly enhancing patient prognosis and quality of life.

Uses

• Treatment of chronic myeloid leukemia (CML).
• Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Treatment of unresectable and/or metastatic gastrointestinal stromal tumors (GIST).
• Certain myelodysplastic/myeloproliferative diseases.

Directions For Use

Take orally once daily with a meal and a large glass of water, as directed by your oncologist. Swallow the tablet whole.

Benefits

• Highly effective targeted therapy for specific cancers.
• Significantly improves survival rates in CML and GIST.
• Reduces disease progression and symptoms.
• Generally better tolerated than traditional chemotherapy.
• Oral administration offers convenience.
• Can induce durable remissions.

Side Effects

• Nausea, vomiting, diarrhea
• Fluid retention (edema, especially periorbital)
• Muscle cramps, musculoskeletal pain
• Fatigue
• Skin rash
• Headache
• Abdominal pain
• Myelosuppression (low blood counts)
• Liver enzyme elevation
• Weight gain
• Cardiac dysfunction (rare)
• Hypothyroidism (rare)

Safety Measures

• Alcohol - Moderate alcohol consumption is generally not contraindicated, but excessive intake should be avoided due to potential for liver enzyme elevation, which can be exacerbated by imatinib.
• Pregnancy - Not recommended during pregnancy due to potential for fetal harm. Effective contraception is advised for women of childbearing potential during treatment and for a period after.
• Breastfeeding - Not recommended during breastfeeding as imatinib is excreted into breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution in patients with liver impairment. Dose adjustments may be necessary, and liver function should be monitored regularly.
• Kidney - Use with caution in patients with kidney impairment. Dose adjustments may be required, and renal function should be monitored.
• Lung - Rare cases of interstitial lung disease or pulmonary hypertension have been reported. Use with caution in patients with pre-existing lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.